Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

186 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
OLIGOPELVIS GETUG P07, a Multicenter Phase II Trial of Combined High-dose Salvage Radiotherapy and Hormone Therapy in Oligorecurrent Pelvic Node Relapses in Prostate Cancer.
Supiot S, Vaugier L, Pasquier D, Buthaud X, Magné N, Peiffert D, Sargos P, Crehange G, Pommier P, Loos G, Hasbini A, Latorzeff I, Silva M, Denis F, Lagrange JL, Morvan C, Campion L, Blanc-Lapierre A. Supiot S, et al. Among authors: sargos p. Eur Urol. 2021 Oct;80(4):405-414. doi: 10.1016/j.eururo.2021.06.010. Epub 2021 Jul 8. Eur Urol. 2021. PMID: 34247896 Clinical Trial.
[Postoperative radiotherapy of prostate cancer].
Richaud P, Sargos P, Henriques de Figueiredo B, Latorzeff I, Mongiat-Artus P, Houédé N, Salomon L, Wallerand H. Richaud P, et al. Among authors: sargos p. Cancer Radiother. 2010 Oct;14(6-7):500-3. doi: 10.1016/j.canrad.2010.07.224. Cancer Radiother. 2010. PMID: 20810300 Review. French.
Definition of lymph node areas for radiotherapy of prostate cancer: A critical literature review by the French Genito-Urinary Group and the French Association of Urology (GETUG-AFU).
Sargos P, Guerif S, Latorzeff I, Hennequin C, Pommier P, Lagrange JL, Créhange G, Chapet O, de Crevoisier R, Azria D, Supiot S, Habibian M, Soulié M, Richaud P. Sargos P, et al. Cancer Treat Rev. 2015 Dec;41(10):814-20. doi: 10.1016/j.ctrv.2015.10.005. Epub 2015 Oct 23. Cancer Treat Rev. 2015. PMID: 26508669 Review.
Post-Prostatectomy Image-Guided Radiotherapy: The Invisible Target Concept.
Vilotte F, Antoine M, Bobin M, Latorzeff I, Supiot S, Richaud P, Thomas L, Leduc N, Guérif S, Iriondo-Alberdi J, de Crevoisier R, Sargos P. Vilotte F, et al. Among authors: sargos p. Front Oncol. 2017 Mar 9;7:34. doi: 10.3389/fonc.2017.00034. eCollection 2017. Front Oncol. 2017. PMID: 28337425 Free PMC article. Review.
Adult prostatic sarcoma: A contemporary multicenter Rare Cancer Network study.
De Bari B, Stish B, Ball MW, Habboush Y, Sargos P, Krengli M, Bossi A, Stabile A, Sole Pesutic C, Lestrade L, Smeenk RJ, Jereczek-Fossa BA, Zilli T, Créhange G, Alongi F, Zaorsky N, Ozsahin M. De Bari B, et al. Among authors: sargos p. Prostate. 2017 Jul;77(10):1160-1166. doi: 10.1002/pros.23375. Epub 2017 Jun 8. Prostate. 2017. PMID: 28594087
Dose constraints for moderate hypofractionated radiotherapy for prostate cancer: The French genito-urinary group (GETUG) recommendations.
Langrand-Escure J, de Crevoisier R, Llagostera C, Créhange G, Delaroche G, Lafond C, Bonin C, Bideault F, Sargos P, Belhomme S, Pasquier D, Latorzeff I, Supiot S, Hennequin C. Langrand-Escure J, et al. Among authors: sargos p. Cancer Radiother. 2018 Apr;22(2):193-198. doi: 10.1016/j.canrad.2017.11.004. Epub 2018 Apr 5. Cancer Radiother. 2018. PMID: 29628205
[Radiation therapy in patients with inflammatory bowel disease. A review].
Jmour O, Pellat A, Colson-Durand L, To NH, Latorzeff I, Sargos P, Sobhani I, Belkacemi Y. Jmour O, et al. Among authors: sargos p. Bull Cancer. 2018 May;105(5):517-522. doi: 10.1016/j.bulcan.2018.02.005. Epub 2018 Apr 10. Bull Cancer. 2018. PMID: 29653817 Review. French.
186 results